<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Acetylsalvianolic acid A (ASAA) is a semisynthetic analogue of salvianolic acid A isolated from Danshen (Salvia miltiorrhiza Bunge) </plain></SENT>
<SENT sid="1" pm="."><plain>A rat middle cerebral artery <z:mp ids='MP_0005048'>thrombosis</z:mp> model was made by adding <z:chebi fb="0" ids="30808">FeCl3</z:chebi> to the surface of the right middle cerebral artery (<z:chebi fb="70" ids="34342">MCA</z:chebi>) </plain></SENT>
<SENT sid="2" pm="."><plain>Using this model, the protective effects of ASAA on focal cerebral ischemic injury were studied </plain></SENT>
<SENT sid="3" pm="."><plain>The neurologic status of each rat was carefully evaluated at 4, 8 and 24 h after surgery </plain></SENT>
<SENT sid="4" pm="."><plain>The <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> and the morphological changes of brain tissue were examined </plain></SENT>
<SENT sid="5" pm="."><plain>Pretreatment with ASAA 50 or 100 mg.kg-1 iv was shown to significantly reduce the <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> and attenuate neurological deficits </plain></SENT>
<SENT sid="6" pm="."><plain>The degree of inhibition of <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> were 46.5% (P &lt; 0.05) and 87.4% (P &lt; 0.01), respectively </plain></SENT>
<SENT sid="7" pm="."><plain>In pathological examination, pretreatment with ASAA 100 mg.kg-1 iv, there was no <z:mp ids='MP_0005048'>thrombosis</z:mp> or only a little <z:mp ids='MP_0005048'>thrombosis</z:mp> in <z:chebi fb="70" ids="34342">MCA</z:chebi> </plain></SENT>
<SENT sid="8" pm="."><plain>The extent of tissue <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> was much less than that of control </plain></SENT>
<SENT sid="9" pm="."><plain>These results indicate that the beneficial effects of ASAA on focal cerebral ischemic rats subjected to middle cerebral artery <z:mp ids='MP_0005048'>thrombosis</z:mp> may be related to its antithrombotic effect </plain></SENT>
</text></document>